Align Technology | ALGN - Operating Expenses

Stock Price
189.59
Daily Change
-1.08 -0.57%
Monthly
5.17%
Yearly
3.40%
Q2 Forecast
185.89

Align Technology reported $822.85M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
3M USD 3.26B 1.66B Mar/2026
Align Technology USD 822.85M 11.8M Dec/2025
Becton, Dickinson and Co. USD 4.59B 476M Dec/2025
Bruker USD 900.9M 124.3M Dec/2025
Cardinal Health USD -2.88B 5M Dec/2025
Charles River Laboratories USD 918.41M 2.49B Dec/2025
Cooper Companies USD 811.3M 113.5M Dec/2025
CVS Health USD 103.58B 3.66B Dec/2025
Danaher USD 52.95B 47.61B Mar/2026
Dentsply International USD 423M 1.06B Dec/2025
Dexcom USD 936.6M 30.2M Dec/2025
Henry Schein USD 3.25B 110M Dec/2025
Idexx Laboratories USD 774.97M 24.58M Dec/2025
Insulet USD 637.5M 48.9M Dec/2025
Integra LifeSciences USD 368.92M 668.65M Dec/2025
IQVIA Holdings USD 1.69B 4.47B Dec/2025
Masimo USD 328.6M 181.6M Dec/2025
McKesson USD 104.5B 2.85B Dec/2025
Mettler Toledo International USD 777.8M 42.3M Dec/2025
Revvity USD 626.22M 25.62M Dec/2025
Solventum Corp USD 1.89B 3.09B Dec/2025
Stryker USD 5.2B 505M Dec/2025
Teleflex USD 532.64M 3.29B Dec/2025
Thermo Fisher Scientific USD 9.09B 821M Mar/2026
Veeva Systems USD 590.07M 19.69M Dec/2025
Waters USD 661.85M 1.67B Dec/2025
Zimmer Biomet Holdings USD 1.94B 277.8M Dec/2025
Zoetis USD 1.55B 3.85B Dec/2025